| Board of
Directors |
Chairman and General Manager: Mr.
Mohammad Rushdi Al-Najami |
| Paid
Capital
|
$6,300,000 US
|
| Personnel |
200 employees |
| Company
Classification |
Limited private shareholding
|
|
Markets |
Iraq, Yemen, Sudan, Algeria, Saudi
Arabia, Bahrain, Oman, Lebanon and UAE. |
| Therapeutic Categories |
Antibiotics, antiparasitics, antivirals, anxiolytics and antidepressants,
antiparkinson drugs, capillary regulators, central nervous system
stimulants, peripheral and cerebral vasodilators, antihypertensives,
anti-estrogens, analgesics and anti-inflammatories, respiratory drugs,
gastrointestinal drugs, iron preparations, antihyperglycemic agents,
diuretics, antihyperuricemia (antigout), cholesterol lowering agents,
antiprolactin hormone, vitamin B6 (Pyridoxine), antihelminthics and
antimalarials, Bone resoption inhibitors, Erectile dys function products.
|
|
Certification |
ISO 9002 |
| Address |
P.O. Box 211, Sahab, 11512 Jordan
|
| Telephone |
++ 962-6-402 3950, ++ 962-6-534 0216 |
| Fax |
++ 962-6-402 3749
|
| E-mail |
info@ram-pharma.com |
| Web Site |
www.ram-pharma.com
|
|